CN Patent

CN103800325A — 吡非尼酮的新用途

Assigned to Individual · Expires 2014-05-21 · 12y expired

What this patent protects

本发明提供了吡非尼酮在制备抗血管新生的药物中的用途。本发明还提供了一种治疗湿性黄斑变性的药物。吡非尼酮能够有效抑制脉络膜血管新生，滴眼和眼内注射均有良好活性，可用于眼科血管新生性疾病的治疗，尤其是对湿性黄斑变性具有明显治疗作用，为临床用药提供了新选择。

USPTO Abstract

本发明提供了吡非尼酮在制备抗血管新生的药物中的用途。本发明还提供了一种治疗湿性黄斑变性的药物。吡非尼酮能够有效抑制脉络膜血管新生，滴眼和眼内注射均有良好活性，可用于眼科血管新生性疾病的治疗，尤其是对湿性黄斑变性具有明显治疗作用，为临床用药提供了新选择。

Drugs covered by this patent

Patent Metadata

Patent number: CN103800325A
Jurisdiction: CN
Classification: —
Expires: 2014-05-21
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.